NCT05210543 Acquisition and Long-term Observation of Patients With Severe Allergic Reactions
| NCT ID | NCT05210543 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charite University, Berlin, Germany |
| Condition | Anaphylaxis |
| Study Type | OBSERVATIONAL |
| Enrollment | 20,000 participants |
| Start Date | 2007-01-01 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20,000 participants in total. It began in 2007-01-01 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Anaphylaxis Registry aims to assess data in a standardized form about symptoms, triggers, cofactors and therapy management from patients who experienced an anaphylactic reaction. This should improve diagnosis and long-term management of these life-threatening allergic reactions.
Eligibility Criteria
Inclusion Criteria: * Anaphylactic reaction within the past 12 months Exclusion Criteria: \-
Contact & Investigator
Margitta Worm, Prof.
STUDY CHAIR
Charite University, Berlin, Germany
Frequently Asked Questions
Who can join the NCT05210543 clinical trial?
This trial is open to participants of all sexes, studying Anaphylaxis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05210543 currently recruiting?
Yes, NCT05210543 is actively recruiting participants. Contact the research team at margitta.worm@charite.de for enrollment information.
Where is the NCT05210543 trial being conducted?
This trial is being conducted at Berlin, Germany.
Who is sponsoring the NCT05210543 clinical trial?
NCT05210543 is sponsored by Charite University, Berlin, Germany. The principal investigator is Margitta Worm, Prof. at Charite University, Berlin, Germany. The trial plans to enroll 20,000 participants.